HDC/IL-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HDC/IL-2, covering 2017-12-19 to 2017-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) [Phase 1, Phase 2]